Fusion Antibodies plc (AIM:FAB)
11.55
-0.45 (-3.75%)
Sep 25, 2026, 11:45 AM GMT
Fusion Antibodies Employees
Fusion Antibodies had 27 employees as of March 31, 2026. The number of employees increased by 3 or 12.50% compared to the previous year.
Employees
27
Change (1Y)
3
Growth (1Y)
12.50%
Revenue / Employee
78.15K GBP
Profits / Employee
-42.56K GBP
Market Cap
15.02M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 27 | 3 | 12.50% |
| Mar 31, 2025 | 24 | -3 | -11.11% |
| Mar 31, 2024 | 27 | -21 | -43.75% |
| Mar 31, 2023 | 48 | -7 | -12.73% |
| Mar 31, 2022 | 55 | 0 | - |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| IXICO | 79 |
| SkinBioTherapeutics | 41 |
| Oxford BioDynamics | 37 |
| Aptamer Group | 30 |
| Palatin Technologies | 29 |
| ImmuPharma | 7 |
| Solvonis Therapeutics | 6 |
| Genflow Biosciences | 5 |